JPRN-UMIN000028626已完成未知
A Prospective, Multi-Center Randomized Phase 3 Trial of Carbon Ion versus Conventional Photon Radiation Therapy for Locally Advanced, Unresectable Pancreatic - A Randomized Phase 3 Trial of Carbon Ion versus Conventional Photon Radiation Therapy for Locally Advanced, Unresectable Pancreatic
niversity of Texas Southwestern Medical Center0 个研究点目标入组 103 人开始时间: 2017年8月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 103
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects receiving other investigational agents. 2.History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine or nab-paclitaxel or other agents used in study. 3.Subjects who are pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants. 4.Prior treatment for pancreatic cancer preceding registration 5.Prior radiation to the upper abdomen 6.Placement of a metal stent for relief of biliary obstruction (metal stents may be placed following completion of radiation therapy). 7.Body weight >100 kg 8.Active inflammatory bowel disease or active gastric/duodenal ulcer 9.Metal implants in the upper abdomen 10.Expected medical intolerance of radiotherapy, concurrent chemotherapy, and/or adjuvant chemotherapy. 11.History of HIV or hepatitis B or C
研究者
相似试验
已完成
4 期
Comparison of WallFlex Biliary Fully Covered metal stents to plastic stents in patients with Chronic PancreatitisCTRI/2012/11/003103Boston Scientific40
尚未招募
3 期
Phase III Trial of R21/Matrix-MMalariaPACTR202102694561794niversity of Oxford4,800
已完成
3 期
A randomized controlled multicenter phase III trial comparing cytoreductive surgery followed by intravenous chemotherapy versus intravenous chemotherapy alone for recurrent platinum-sensitive ovarian cancercancer of the ovaries1003859410029903ovarian cancerNL-OMON35952niversitair Medisch Centrum Sint Radboud230
进行中（未招募）
1 期
A Clinical Trial to Compare How Well Lenvatinib Works in Combination with Everolimus or Pembrolizumab Versus Sunitinib Alone in Patients with Kidney Cancer that has Spread and Who Have Not Previously Been Treated With Anti-Cancer MedicinesAdvanced Renal Cell CarcinomaMedDRA version: 20.0Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-000916-14-CZEisai Ltd.1,050
进行中（未招募）
1 期
A Clinical Trial to Compare How Well Lenvatinib Works in Combination with Everolimus or Pembrolizumab Versus Sunitinib Alone in Patients with Kidney Cancer that has Spread and Who Have Not Previously Been Treated With Anti-Cancer MedicinesAdvanced Renal Cell CarcinomaMedDRA version: 21.1Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-000916-14-BEEisai Ltd.1,050